WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony S. MarucciPRESIDENT CEO2024-11-1111,500$26.82
$308.43kBuy
Elizabeth CrowleySR. VP CPDO2024-06-1430,000$34.87
$1.05MSell
Elizabeth CrowleySR. VP CPDO2024-06-1430,000$10.38
$311.40kBuy
Samuel Bates MartinSVP AND CFO2024-06-1417,172$35.43
$608.32kSell
Samuel Bates MartinSVP AND CFO2024-06-143,201$9.02
$28.86kBuy
Samuel Bates MartinSVP AND CFO2024-06-1416,968$10.38
$176.13kBuy
Diane C. YoungSVP CHIEF MEDICAL OFFICER2024-06-1115,000$2.71
$40.65kBuy
Elizabeth CrowleySR. VP CPDO2024-06-0715,000$35.06
$525.87kSell
Diane C. YoungSVP CHIEF MEDICAL OFFICER2024-06-0745,000$35.26
$1.59MSell
Elizabeth CrowleySR. VP CPDO2024-06-077,500$9.02
$67.63kBuy

1 of 4

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP13.52%8,975,833$164.26MInstitution
Thomas S. Paluck11.50%7,632,346$139.67MInsider
Blackrock Inc8.26%5,480,670$100.30MInstitution
Kynam Capital Management LP7.63%5,064,207$92.67MInstitution
Fmr LLC7.32%4,857,668$88.90MInstitution
Vanguard Group Inc5.85%3,881,995$71.04MInstitution
Eventide Asset Management LLC5.65%3,753,260$68.68MInstitution
Price T Rowe Associates Inc5.36%3,557,136$65.10MInstitution
State Street Corp4.87%3,234,961$59.20MInstitution
Bellevue Group Ag4.63%3,071,615$56.21MInstitution

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX85.28%14.72%Net Buying
MESO0.26%0.00%
GPCR35.24%12.56%Net Buying
LQDA43.22%56.78%Net BuyingNet Selling
OCUL78.69%21.31%Net SellingNet Selling
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 111.00% institutional shareholders, 19.16% Celldex Therapeutics insiders, and 0.00% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 11.50% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $139.67M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.